The (Failed) Development of a Biotechnology Cluster: The Case of Lombardy
By L. Orsenigo. 2001
120 citations recorded by the source corpus.
Subfields: Accounting, Economics and Econometrics, Strategy and Management
View Paper: https://www.semanticscholar.org/paper/7cca39a15a236442b692bbd61353ef86e093fde4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Accounting
- Johanna L. Francis
- Maryann P. Feldman
- Margarida Fontes
- Rolf Sternberg
- Ethan Mollick
- B. Spigel
- E. Malecki
- E. Stam
In Economics and Econometrics
- Maryann P. Feldman
- Margarida Fontes
- Johanna L. Francis
- Weiping Wu
- B. Spigel
- E. Stam
- Robert Huggins
- Lokesh Dani
In Strategy and Management
- Maryann P. Feldman
- Margarida Fontes
- Johanna L. Francis
- Weiping Wu
- B. Spigel
- E. Stam
- Markus Perkmann
- Brian T. Pentland
Citations in the corpus
- Homegrown Solutions: Fostering Cluster Formation (2004, background): “Evidence on the location of the biotech industry highlights the importance of the location of the chemical and pharmaceutical industries, especially their headquarters and research and development laboratories (Gray & Parker, 1998; Orsenigo, 2001; Zeller, 2001).”
- The Locational Dynamics of the U.S. Biotech Industry: Knowledge Externalities and the Anchor Hypothesis (2005, background): “The biotech industry in Italy developed in Milan which did not have the top-rated academic research while Naples, an important academic center, did not develop a biotech industry (Orsenigo 2001:83).””
- Distant networking: The knowledge acquisition strategies of 'out-cluster' biotechnology firms (2005, background): “…sometimes very specialized knowledge base, which may require close interaction with large firms, with greater integrative capacities (McKelvey & Orsenigo, 2001); (iii) to gain access to markets for technology and/or downstream competences related with regulation, production and…”